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A​BSTRACT 
Sensitization of colorectal afferents and colorectal hypersensitivity have been         
observed in a mouse model of post-infectious irritable bowel syndrome via           
intracolonic treatment of 2,4,6-trinitrobenzenesulfonic acid (TNBS). In this study, we          
investigated the distribution and morphology of microscopic colorectal afferent         
endings before and after intracolonic treatment of TNBS. We genetically labeled           
predominantly extrinsic colorectal afferents using the vesicular glutamate transporter         
type 2 (VGLUT2) promoter. Then, we used an optical tissue clearing method of             
whole-mount colorectum to image labeled VGLUT2-nerve endings that are otherwise          
obscured in untreated samples. We used vector path tracing to quantify the density             
and degree of curliness of colorectal nerve endings in various sub-volumes of the             
colroectum captured via confocal imaging. VGLUT2-labeled nerve fibers were         
observed in all layers except the serosa and longitudinal muscle, although they were             
most abundantly present in the submucosa, myenteric plexus, and mucosa. Seven days            
after TNBS treatment, the density of VGLUT2-positive neural tissues were          
significantly reduced in these three layers. The TNBS-induced loss of VGLUT2 tissue            
density recovered in most cases by day 28 of TNBS injection. Interestingly, almost all              
VGLUT2-positive nerve endings in the submucosa displayed a much higher degree of            
curliness compared to those in other layers in both the control and treated             
colorectums. However, TNBS treatment significantly reduced the presence of         
severely curly nerve endings in the rectal region 28 days post-TNBS. The results from              
this morphological study along with previous findings of functional         
mechanotransduction studies point to the role of curly afferent endings in the            
submucosa in the encoding of noxious visceral stimuli i.e. in visceral nociception.  
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I​NTRODUCTION 
Irritable Bowel Syndrome (IBS) is a chronic gastrointestinal (GI) disorder          
that affects about 10-20% of the American population by disrupting normal bowel            
movement and causing abdominal pain and discomfort (30). Despite the known           
prevalence of IBS, its diagnosis and treatment remain challenging for physicians           
globally due to the poor understanding of the mechanisms underlying the pain            
experienced. The chief symptom that IBS patients report to gastroenterologists is           
chronic visceral pain. In contrast to acute visceral pain, which likely indicates a             
medical emergency due to physical damage in the viscera, chronic visceral pain            
manifests without any apparent damage (7). The lack of apparent damage makes it             
difficult to treat patients via surgical or clinical interventions. This leads to the             
classification of disorders such as IBS as “functional disorders” in which the            
diagnosis is based on the symptoms but not on any detectable structural or             
biochemical abnormalities (7).  
Since patients present IBS-related visceral pain without any structural defects          
or mechanical insult, alleviating symptoms requires focusing on the neural encoding           
of the pain rather than surgical interventions. Clinical studies reveal that the persistent             
sensitization of colorectal afferents is necessary to sustain the perception of chronic            
visceral pain in IBS patients (21, 31, 32). Preclinical rodent models have            
demonstrated that sensitized colorectal afferents result in behavioral visceral         
hypersensitivity (7, 22, 24, 29). Subthreshold firing of both mechanosensitive and           
mechanically insensitive extrinsic colorectal afferents, induced by treatment with         
2,4,6-trinitrobenzenesulfonic acid (TNBS), is correlated with behavioral changes (8).         
Specifically, the TNBS mouse model introduces post-infectious irritable bowel         
syndrome (PI-IBS) symptoms such as afferent sensitization and behavioral         
hypersensitivity.  
Visceral pain is unique in that it is generally caused by mechanical stimuli             
such as colorectal distension in IBS. However, other types of stimuli such as cutting,              
pinching, and heat are not sufficient at evoking visceral pain (7). Therefore,            
mechanotransduction is a key research focal point when it comes to understanding            
visceral pain. The transduction of colorectal distension into sensory information i.e.           
conversion of mechanical information into action potentials, has been studied          
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extensively in colorectal afferents through extracellular single-unit recording studies         
(6, 9, 11, 12), and less extensively in intracellular recordings from afferent cell bodies              
in the dorsal root ganglion (DRG) (14, 20). The neural encoding measured in these              
studies is initiated at the nerve endings found throughout the various layers of the              
colorectal wall (9, 34). Despite their vital role in initiating the perception of both              
physiological and pathophysiological information, colorectal afferent nerve endings        
remain understudied.  
Existing knowledge about colorectal nerve endings comes from dye-labelling         
studies that reveal their physical locations and general morphology in layers through            
the thickness of the colorectal wall (27, 28). In a previous study that used              
immunohistochemistry, a general reduction of neuronal tissues was observed in the           
colorectum seven days post-TNBS injection which recovered 14-28 days         
post-injection (8). However, the extent to which the distribution, density, and           
morphology of specifically extrinsic colorectal afferent endings are altered remains          
unclear in IBS-related visceral hypersensitivity.  
Extrinsic afferents, which originate in the DRG, are glutamatergic neurons and           
thus express one of three vesicular glutamate transporter (VGLUT) subtypes          
(VGLUT1, VGLUT2, and VGLUT3) (19). Specifically, colorectal afferents mainly         
express VGLUT2 and remaining subtypes account for less than 10% of DRG            
colorectal afferent neurons (3). Additionally, channelrhodopsin2 tagged with        
fluorescent protein EYFP (ChR2-EYFP) was used in functional characterization         
studies because it was found to be reliably transported to afferent endings (6, 34).              
Therefore, in this study we quantified the morphological changes of afferent endings            
post TNBS treatment in Cre-LoxP transgenic mice. We used Cre-LoxP transgenic           
mice in which the VGLUT2 promoter drove the expression of ChR2-EYFP. We            
found that 78% of DRG afferent neurons were tagged with VGLUT2-Cre as opposed             
to only 2.6% of myenteric neurons. This confirms that the VGLUT2 promoter drives             
the expression of predominantly extrinsic afferents and a very small population of            
enteric neurons. Following genetic labelling of VGLUT2-positive afferents, we         
performed optical tissue clearing of whole-mount colorectums using a SeeDB protcol           
(16) for confocal imaging, revealing fine nerve endings throughout the depth of the             
colorectal wall. The 3-dimensional stacks acquired from confocal imaging allowed for           
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vector path tracing to study physical characteristics of individual nerve endings before            
and after TNBS treatment.  
M​ETHODS 
All experimental procedures were reviewed and approved by the University of           
Connecticut Institutional Animal Care and Use Committee. 
Optical clearing by adapting the SeeDB protocol 
To optically clear the colorectum, we adopted the protocol published by Ke et. al,              
which was originally developed for clearing mouse brain tissues (16). Briefly, the            
fixed samples were rinsed with PBS for three times and then submerged in 20-30 mL               
of 20%, 40%, 60%, 80%, 100% (wt/vol) fructose for 3h, 3h, 12h, 12h, and 24h,               
respectively. Afterwards, the samples were submerged in SeeDB solution (80.2%          
wt/wt fructose) for 24 h. The 20-100% fructose solutions were prepared with diluted             
PBS solution (10 times dilution) and the SeeDB solution was prepared with deionized             
H​2​O. The whole clearing process was conducted in a dark environment with sample             
tubes placed on a gentle shaker at room temperature. Samples were further incubated             
in a refractive index matching solution (RIMS, see (16) for details) overnight at 4 °C               
and divided longitudinally into three 10-mm-long segments as shown in ​Fig. 1B ​, i.e.             
the colonic, intermediate, and rectal regions (from proximal to distal) according to our             
previous reports (26, 33). We mounted each segment in RIMS on glass slides and              
sealed the coverslip with nail polisher. Incubating and mounting samples in RIMS            
with an refractive index (RI) of ~1.47 enhanced the optical clarity by reducing the              
mismatch of RIs between the processed sample and the glass microscope objective. 
PI-IBS mouse model by intracolonic TNBS treatment 
Mice were lightly anesthetized (isoflurane), and either saline or TNBS (0.2 ml @             
10 mg/ml in 50% ethanol; Sigma-Aldrich, St. Louis, MO) was administered           
transanally via a 22-gauge feeding needle with an oval-shaped tip of Ø1.25 mm             
(#18061-22, Fine Science Tools, Foster City, CA). Under anesthesia, mice were held            
in a head down position (~30°) for five minutes to ensure retention of TNBS in the                
colon. After the injection of TNBS, access to food and water in the cage was               
available. Our prior study indicated significant loss of nerve fibers in the colorectum             
at day 7 post TNBS treatment and complete recovery by day 28 (8). Accordingly, we               
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 designed the current study to assess nerve fiber density and morphology in            
VGLUT2/ChR2 mice at days 7 and 28 post TNBS. 
 
Tissue preparation for whole-mount optical clearing 
Seven or 28 days after intracolonic TNBS or saline, mice were deeply            
anesthetized (isoflurane), and euthanized by transcardiac perfusion from the left          
ventricle with ice-cold oxygenated Krebs solution (in mM: 117.9 NaCl, 4.7 KCl, 25             
NaHCO​3​, 1.3 NaH​2​PO​4​, 1.2 MgSO​4​, 2.5 CaCl​2​, and 11.1 D-glucose). The excised ~30             
mm of distal colorectum was cannulated and distended to 20 mmHg with phosphate             
buffered saline (PBS) using a custom-built distending device, an innocuous pressure           
that prevents colorectal wall folding. The colorectum was distended for 1 minute,            
rested for 1 minute, and distended/rested five times. After the distending protocol, the             
colorectum generally displayed a cylindrical shape as shown in ​Fig. 1A​. The            
colorectum was then cut open along the mesentery and fixed with 4% (wt/vol)             
paraformaldehyde (PFA, Sigma-Aldrich, St. Louis, MO) dissolved in PBS at 4 °C for             
3 hours. 
Whole-mount Immunostaining of the colorectum 
To quantitatively determine the expression efficiency of the VGLUT2-Cre mice,          
we conducted immuno-staining on the whole-mount colorectum harvested from both          
VGLUT2/ChR2 and VGLUT2/tdT mice. Mice were euthanized via isoflurane         
inhalation and perfused with a calcium-free Krebs solution containing 10 mM EDTA            
and 1 µM nifedipine (Sigma-Aldrich, St. Louis, MO). Distal colons were harvested            
and distended using the same distending protocol as described above. Inflated colons            
were fixed in the tubular shape in 4% PFA at 4 °C for 30 min. The fixed tissues were                   
washed in PBS with 0.1% Triton X-100 (Sigma-Aldrich, St. Louis, MO) and then             
incubated in a blocking solution containing 4% donkey serum, 0.4% Triton X-100 and             
1% bovine serum in PBS for 45 minutes (4). To visualize neural somata, the tissues               
were incubated with a mouse biotin-conjugated monoclonal antibody against         
HuC/HuD (1:200, Fisher Scientific, East Greenwich, RI) for 48 hours at 4 °C, and              
then were incubated in Streptavidin conjugated with Alexa Fluor 594 (1:200, Jackson            
ImmunoResearch, West Grove, PA) for 2 hours at room temperature. The colorectum            
was then flattened, whole-mounted on diamond white glass slides serosal side up            
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(Globe Scientific, Inc., Mahwah, NJ), covered by thin glass slips (Corning, Inc.,            
Corning, NY), and imaged at the myenteric plexus using a confocal microscope            
(A1R, Nikon Inc., Melville, NY). 
Imaging throughout colorectal wall under confocal microscope 
Cleared colorectal samples were mounted serosal side up in RIMS on diamond            
white glass slides and covered by thin glass slips. The colorectal wall (thickness from              
100 to 300 µm) was scanned from serosa to mucosa by Nikon A1R spectral confocal               
microscope (Nikon Inc., Melville, NY) using a 40x Plan Fluor Oil immersion            
objective (working distance 240 µm, NA 1.30). To capture fine structures of            
unmyelinated nerve endings (~1 µm thick according to (18)), we scanned the sample             
at 0.3 µm step size and 1024x1024 pixel resolution either through the wall thickness              
or up to 200 µm, limited by the working distance of the 40x objective. We               
implemented intensity correction in the Z direction to increase the scanning laser            
power for deep tissues. We conducted image acquisition by setting the parameters in             
the Nikon NIS-Elements software suite that came with the microscope. In each            
sample, 2 image stacks were recorded at random locations. To avoid confounding            
factors, areas with large blood vessels that showed strong autofluorescence were not            
imaged.  
Vector path tracing of VGLUT2-positive nerve fibers from image stacks 
The 3-dimensional volume from confocal image stacks through the colorectal          
wall was divided into sub-volumes following the anatomical separation of          
longitudinal muscular, myenteric plexus, circular muscular, submucosal and mucosal         
layers. In each sub-volume except the myenteric plexus, VGLUT2-positive nerve          
fibers were traced using a semi-automated neurotracing plugin in ImageJ software           
(version 1.8.0; NIH), i.e., “Simple Neurite Tracer” (18), which approximated each           
curly nerve fiber with a vector path consisting of many linear segments. The traced              
vector paths were extracted as x, y and z coordinates at the ends of the full path as                  
well as their lengths to allow post-hoc statistical analysis of nerve fibers. Vector path              
tracing was not performed in the myenteric plexus, where nerve fibers clustered into             
thick bundles to prevent definitive tracing of individual fibers.  
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Quantification of VGLUT2-positive nerve fibers 
Nerve fiber density quantified as length per volume - After vector path tracing, the              
densities of VGLUT2-positive nerve fibers in the longitudinal muscular, circular          
muscular, submucosal and mucosal layers were calculated as total nerve fiber length            
divided by tissue volume. The total fiber length in each tissue volume was acquired              
by summing all traced vector paths within the volume. 
Nerve fiber density quantified as percentage of fluorescent signals - Unlike other            
layers of the colorectum, many VGLUT2-positive nerve fibers organize into thick           
bundles that weave into a mesh-like network; individual nerve fibers cannot be            
definitively traced in those bundles. Thus, we quantified the VGLUT2-positive nerve           
tissue density in the thin myenteric plexus as the area percentage of fluorescent             
signals. Detection of the fluorescent signal threshold was reported previously (13).           
Using ImageJ, we projected each myenteric plexus image stack with “maximum           
intensity z-projection” to convert it into an 8-bit grayscale image. The threshold was             
set to exclude at least 99.99% of the background intensity based on its Gaussian              
distribution. The threshold value was calculated from the standard normal distribution           
(Z) equation: threshold=3.72 SD + m, ​where 3.72 was the ​Z​-score at ​P = 0.9999, SD                
and m were the Standard Deviation and mean of background intensities in 8-bit             
grayscale (0-255), respectively. ​The percentage of fluorescent signals was calculated          
as the area ratio above the threshold in the 8-bit grayscale image. 
Fiber ending curliness - The distal afferent endings (50 to 300 µm) in the              
colorectum are putative transducer zones for encoding external stimuli into trains of            
action potentials. Many of the distal VGLUT2-positive nerve endings are curly and            
“meandering”, suggesting their mechano-nociceptive roles for encoding only noxious         
and tissue-injurious colorectal deformation. From vector path tracing, we defined the           
“curliness” of individual nerve endings (​c​) as the ratio between the ending path length              
and the direct distance between the two ends of the endings:  
 c = L
√(x2−x1) +(y2−y1) +(z2−z1)2 2 2
where is the nerve ending length, and and are L        x1, y1, z1)(     x2, y2, 2)(  z   
coordinates of the two ends. The curliness is 1 for an ideally straight nerve ending,       c          
and greater than 1 for curly and meandering endings. 
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Data analysis 
Data were presented as means ± SD. One-way and two-way analysis of variance             
(ANOVA) were used to test the differences between control and treated groups.            
Differences were considered significant when ​p ​value<0.05. Statistical analysis was          
performed using SigmaPlot version 9.0 (Systat Software, San Jose, CA). 
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R​ESULTS 
Optical clearing of mouse colorectum for through-thickness imaging 
As shown in ​Fig. 1A​, the colorectum is distended by 20 mmHg pressure             
(threshold for physiologically noxious distension) following the protocol described in          
Methods. As displayed in bright field photographs in ​Fig. 1B, ​the ​cleared colorectum             
shows more glass-like transparency than the uncleared counterpart. Displayed in ​Fig.           
1C is a comparison of z-stack confocal microscope images of uncleared (125 µm) and              
cleared (78 µm) colorectal walls from VGLUT2/ChR2 mice. Thick nerve bundles in            
the myenteric plexus are captured in the uncleared colorectum, but individual microns            
thick nerve endings are only visible in the cleared colorectum (marked by the white              
arrowhead) and obscured in the uncleared counterpart.  
 
Fig. 1. ​Optical clearing of the mouse colorectum for through-thickness imaging. 
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Validation of VGLUT2 expression in colorectal nerve innervations 
Displayed in ​Figs. 2A and ​2B are confocal images from cleared colorectum            
harvested from VGLUT2/tdT and VGLUT2/ChR2 mice, respectively. Both reporter         
lines reveal comparable VGLUT2-positive neural tissue patterns in the myenteric          
plexus, i.e., the mesh-like thick nerve bundles connecting the myenteric ganglions.           
However, the tdT reporter is inferior at labeling the individual fine fibers in the              
submucosal layer as compared with the ChR2 reporter. Both tdT and ChR2 reporter             
lines are efficient in labeling the cell somata in the myenteric ganglion as indicated by               
arrowheads in ​Figs. 2A and ​2B​. Thus, we used both reporter lines to quantify the               
proportions of positive neurons in the myenteric plexus and exclusively used the            
VGLUT2/ChR2 mice for quantification of nerve endings in the colorectum. 
 
Fig. 2.​ Validation of VGLUT2 expression in colorectal nerve innervations.  
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In our previous study using the tdT reporter line, we reported that VGLUT2-Cre             
induced the expression of 68% of colorectal afferent neurons in the DRG (​1​3). To              
assess the expression efficiency in the enteric nervous system, we marked the neural             
somata with anti-Hu antibody as shown in ​Fig. 2C​, which reveals that VGLUT2-Cre             
only induced the expression in a very small fraction of myenteric neurons            
(2.62±1.88%, 7/266 in total, quantified in 5 myenteric ganglions). We did not observe             
any VGLUT2-positive somata in the submucosal plexus (data not shown), consistent           
with our prior antibody-based immuno-staining results (3). The above results          
collectively indicate that nerve fibers in the VGLUT2/ChR2 colorectum consist of           
mostly extrinsic sensory afferents and a small fraction of intrinsic myenteric fibers. 
 
Through-thickness imaging of VGLUT2-positive fibers in the colorectum 
Image stacks of VGLUT2-positive fibers in cleared colorectum were taken via           
confocal microscopy at 0.3 µm step through the wall thickness from the serosal to the               
mucosal side, or up to 200 µm (limited by the working distance of the 40x objective).                
Displayed in ​Fig. 3 are typical z-stack images at five anatomically distinct layers of              
the colorectum: mucosal (M), submucosal (SM), circular muscular (CM), myenteric          
plexus (MP), and serosal & longitudinal muscular (S-LM) layers. VGLUT2-positive          
nerve fibers are abundantly present at submucosal and myenteric plexus layers, which            
coincide with regions of the two enteric plexuses in the colorectum.           
VGLUT2-positive nerve fibers are also widely present around the crypts in the            
mucosal layer and present to a lesser degree in the circular muscular layers. No nerve               
fibers are definitively embedded in the muscle bundles in the longitudinal muscular            
layer. Also, no VGLUT2-positive fibers are detected in the serosal layer. Typical            
images of VGLUT2-positive fibers in colorectums harvested at day 7 and 28 post             
TNBS treatment are also displayed in ​Fig. 3​. In the colorectums harvested from day 7               
post TNBS, we detected regions with apparently reduced numbers of          
VGLUT2-positive nerve fibers as indicated by the white arrowheads. In colorectums           
from day 28 post TNBS, we did not observe an apparent reduction of             
VGLUT2-positive nerve fibers in any layer.  
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Fig 3. ​Typical confocal images were taken from colorectums harvested from control            
and TNBS-treated mice at day 7 (TNBS-D7) and day 28 (TNBS-D28). M: mucosa,             
SM: submucosa, CM: circular muscular layer, MP: myenteric plexus, S-LM: serosal           
& longitudinal muscular layer.  
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Quantification of the density of VGLUT2-positive nerve fibers in the colorectum  
As described in Methods, we quantified the density of nerve fibers in the             
myenteric plexus by calculating the area fraction of VGLUT2-positive fluorescent          
signals. Displayed in ​Fig. 4A is a representative image stack of a 25 μm-thick              
myenteric plexus, which was transformed into an 8-bit z-stack image (intensity from 0             
to 255) and further converted into a binary image by setting a detection threshold              
based on the mean (3.619) and standard deviation (1.379) of the background intensity.             
The area fraction of the VGLUT2-positive nerve fibers was determined by dividing            
the mean intensity of the binary image 58.007 by 255, i.e., 22.75%.  
 
 
Fig. 4. ​Quantification of the density of VGLUT2-positive nerve fibers. 
 
In contrast, fiber density in muscularis, submucosa, and mucosa was          
quantified by vector path tracing using the “simple neurite tracer” plug-in in ImageJ.             
As shown in a typical example in ​Fig. 4B, ​individual free nerve endings (marked by               
arrow) and thick nerve bundles consisting of many axons (marked by double-arrow)            
were both present in the tissue. For consistent analysis, we only quantified free nerve              
endings and did not include nerve bundles in the analysis. The total length of free               
nerve fibers in ​Fig. 4B is 4036 µm in a volume of 2.180×10​6 (322.18×322.18×21)              
µm​3​, resulting in a fiber density of 1.85 m/mm​3​. 
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As summarized in ​Fig. 5​, the density of VGLUT2-positive fibers was           
determined at random locations in the colonic, intermediate and rectal segments of            
five colorectums harvested from control VGLUT2/ChR2 mice receiving intracolonic         
saline treatment. VGLUT2-positive nerve density in the myenteric plexus (MP),          
circular muscular (CM), and mucosal (M) layers is comparable in all three            
longitudinal segments. In contrast, nerve density in the submucosal (SM) layer is            
significantly higher in the colonic segment than in the other two distal segments (p              
<0.001). Nerve fibers are absent in the serosal & longitudinal muscular (S-LM) layers             
in all three longitudinal segments.  
In the colonic segments, nerve fiber density in the CM layer is significantly             
lower than in the SM and M layers. In the intermediate segments, the fiber density in                
the CM and SM layers were comparable but significantly lower than in the M layer.               
In rectal segments, the fiber density in the CM layer was lower than in the M layer but                  
comparable with the fiber density in the SM layer. Overall, the nerve fiber density is               
the lowest in the CM layer in all three segments.  
 
 
Fig. 5. VGLUT2-positive nerve fiber densities quantified as nerve length per unit            
volume in serosal & longitudinal muscular (S-LM), circular muscular (CM),          
submucosal (SM) and mucosal (M) layers. As indicated with blue bars, neural tissue             
density in the myenteric plexus (MP) was quantified as the area fraction of positive              
fluorescent signals shown in the right y axis. ​n is the number of image stacks in each                 
bar graph. 
 
 
 
15 
 
Loss (day 7) and recovery (day 28) of VGLUT2-positive nerve fibers following            
intracolonic TNBS treatment  
As shown in ​Fig. 6A, ​nerve fiber density in circular muscular layers is unaffected              
by TNBS treatment in all three longitudinal segments. In contrast, nerve fiber density             
is significantly reduced for the TNBS D7 group in the myenteric plexus (MP, ​Fig.              
6B​), submucosa (SM, ​Fig. 6C​) and mucosa (M, ​Fig. 6D​) in all three longitudinal              
segments. In the TNBS-D28 group, nerve fiber densities completely recovered to the            
control level in most SM, MP, and M layers. In some areas, nerve density did not                
fully recover at day 28 post TNBS, including in colonic SM (p =0.003), colonic M (p                
= 0.108) and intermediate M (p = 0.158).  
 
Fig. 6. Altered VGLUT2-positive neural signals in all layers of the colorectum            
following intracolonic TNBS treatment. The neural densities in control and          
TNBS-treated colorectums (day 7 and day 28) were quantified in circular muscular            
(A), myenteric plexus (B), submucosal (C) and mucosal layers (D). n is the number of               
image stacks in each bar graph. *: significant difference from control. 
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 TNBS impact on nerve endings curliness in submucosa 
Unlike the VGLUT2-positive nerve fibers in other layers of the colorectum that            
are generally aligned with the basal tissues (e.g., along the circular muscle bundles or              
around the crypts), fibers in the submucosa do not seem to follow any patterns and are                
significantly more meandering and curly. Here, we quantified the curliness in all            
distal nerve endings in the submucosa following the description in Methods. We            
analyzed the curliness of a total of 1148 VGLUT2-positive fibers from 5 control, 10              
TNBS-D7, and 8 TNBS-D28 colorectums. Among the 1148 fibers, 1127 (98.2 %)            
show curliness between 1 and 3, which are arbitrarily divided into three groups as              
fibers with moderate (1 – 1.67), severe (1.67 – 2.33) and extreme curliness (2.33 – 3).  
Displayed in ​Fig. 7A are typical examples of fibers from those three groups. As              
shown in ​Fig. 7B​, ​most of the fibers (>84%) have moderate curliness which was              
unaffected by the TNBS treatment in either proportions or average curliness. The            
proportions of fibers with severe curliness vary from 9.9 to 15.98% across different             
groups. In the TNBS-D7 group, the proportion of severe curliness fibers present a             
negative trend as compared to the control group in all three longitudinal segments             
despite no statistical significance (Fisher’s exact test, p = 0.096 for colonic, p = 0.338               
for intermediate, p = 0.213 for rectal vs. control). In the TNBS-D28 group, the              
proportion of fibers with severe curliness is comparable to the control level at the              
colonic and intermediate segments (14.02%, p = 1.000 for colonic; 11.67%, p = 0.830              
for intermediate vs. control). However, the proportion of fibers with severe curliness            
is significantly lower than the control level in the rectal segment (4.07%, p <0.001).              
The proportion of fibers with extreme curliness is insignificant in all groups (<4.3%)             
and was not analyzed. Pooling the curliness from all three segments, there is no              
statistical difference between the average curliness in control, TNBS-D7 and          
TNBS-D28 groups, which were 1.47 (​n ​=472), 1.42 (​n​=202), and 1.31 (​n​=474),           
respectively.  
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Fig. 7. Quantification of the curliness of nerve endings in the submucosa            
following intracolonic TNBS treatment. A) Typical submucosal nerve endings with          
different levels of curliness, i.e., moderate (1-1.67, green), severe (1.67-2.33,          
magenta), and extreme (2.33-3, cyan). Scale bars, 50 µm. B) The curliness histograms             
of 1127 fibers ranging from 1 to 3 (21 fibers with curliness beyond 3 were excluded).  
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D​ISCUSSION 
The main innovation is this study was to systematically label a majority of             
extrinsic colorectal afferents and study their morphological properties in healthy and           
disease states. This is a significant advancement from prior studies that sparsely            
labeled afferents using anterograde and retrograde transport of dyes to and from the             
colon, respectively (2, 28, 33). The morphological study of extrinsic colorectal           
afferent endings in the colon has traditionally been limited due to the difficulty in              
selectively labeling them. We observed that while tdTomato efficiently labeled cell           
bodies of colorectal afferents in the DRG, it was inefficient at labeling finer nerve              
endings. On the other hand, channelrhodopsin tagged with EYFP efficiently labeled           
finer nerve endings which are widely distributed throughout the depth of the            
colorectal wall. It appears that proteins such as channelrhodopsin that are either            
present in the plasma membrane or transported to it are better at labelling axons and               
nerve endings, whereas cytoplasmic proteins such as tdTomato are better at labelling            
cell bodies of neurons in the DRG.  
The study of whole-mount colorectum has also been limited in the past by             
challenges associated with extensively clearing the tissue. We observed that the           
widely used clearing method known as CLARITY and similar detergent based           
methods were not effective at clearing the colorectum for visualization of nerve            
endings embedded in the wall (15). On the other hand SeeDB, a clearing method              
usually utilized to clear brain tissues (16) was used in this study to succesfully clear               
whole colorectums. Our study has highlighted SeeDB as a convenient alternative to            
traditional optical tissue clearing methods for future neurogastrointestinal        
investigations.  
Our findings about the relative distribution of extrinsic afferent endings in the            
colorectum are consistent with a sparse labeling study that identified the submucosa            
as the region with the highest density of afferent endings (28). Recently, the             
submucosa has been identified as the load-bearing structure of the colon (25, 26). The              
high density of VGLUT2-positive nerve endings in the submucosa and their unique            
levels of curliness point to their potential role in visceral nociception. From            
vector-path tracing, we found that submucosal nerve endings remain less stretched,           
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with an average degree of curliness of 1.47 when the colon was distended at              
20mmHg, which is considered the threshold for noxious distention in the mouse            
colon. Thus, at physiological levels of distension, the submucosal nerve endings likely            
remain loose and not engaged in mechanotransduction.  
In conclusion, we genetically labeled a majority of extrinsic colorectal          
afferents by inducing the expression ChR2-EYFP in VGLUT2-CRE mice. Then, we           
used the SeeDB optical tissue clearing protocol to allow for much more efficient             
confocal microscopy through the depth of the colorectal wall. Using a semi-automated            
vector-path tracing plugin in most regions of the colorectal wall and analysis of the              
VGLUT2-positive fluorescent signals in the myenteric plexus, we compared the          
relative density of VGLUT2-positive nerve tissue in control colorectums as well as            
TNBS-treated ones. VGLUT2-positive nerve endings were found in all layers of the            
wall except for serosa and longitudinal muscle layers. To better characterize the            
morphology of submucosal nerve endings, we quantified the degree of curliness of            
these endings before and after TNBS treatment. Intracolonic TNBS treatment          
significantly reduced the nerve fiber density seven days later in all layers except in the               
serosa and circular muscle layers, followed by recovery in most layers 28 days after              
injection. Most submucosal nerve endings display some level of apparent curliness of            
which about 10% display severe curliness. The proportion of severely curly fibers is             
significantly reduced in TNBS day 7 colorectums and does not recover in TNBS day              
28 rectal colorectums. These findings point to the potential for sensitization of certain             
submucosal nerve endings when challenged with noxious colorectal distension. The          
mechanism for sensitization of mechanosensitive afferent endings and high-threshold         
afferent endings should be validated in future studies by studying the changes to             
submucosal afferents under noxious colorectal distension levels higher than 20mmHg. 
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